Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients (DAFNE Study)

NCT02214771 is registered in ClinicalTrials.gov with Astellas Pharma S.A.S. as lead sponsor.

NCT NCT02214771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02214771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients (DAFNE Study)
Lead sponsor
Astellas Pharma S.A.S.
Phase
Observational
Overall status
Completed
Start date
September 3, 2014
Completion date
August 17, 2017
Enrollment
296 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection